BASEL HASSOUN: Open Payments
NPI 1568579308 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 24 payments from 9 companies in 2025. Trend: 2023 $472 · 2024 $481 · 2025 $715
Food & beverage: $468Education: $247
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $325 |
| Medtronic, Inc. | 7 | $151 |
| Boston Scientific Corporation | 3 | $65 |
| ACCORD HEALTHCARE, INC. | 3 | $56 |
| IMMUNITYBIO, INC. | 1 | $30 |
| Ferring Pharmaceuticals Inc. | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $23 |
| UROGEN PHARMA, INC. | 1 | $22 |
| Antares Pharma, Inc. | 1 | $16 |
Products named: INTERSTIM, Xtandi, Camcevi, ANKTIVA, ADSTILADRIN, AMS 800 Artificial Urinary Sphincter, RYBREVANT, JELMYTO.
Industry payments across OK — which companies pay providers there.
